Cargando…

Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes

BACKGROUND: The human genome contains a large amount of cis-regulatory DNA elements responsible for directing both spatial and temporal gene-expression patterns. Previous studies have shown that based on their mRNA expression breast tumors could be divided into five subgroups (Luminal A, Luminal B,...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Himanshu, Nord, Silje H, Frigessi, Arnoldo, Børresen-Dale, Anne-Lise, Kristensen, Vessela N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441847/
https://www.ncbi.nlm.nih.gov/pubmed/22616941
http://dx.doi.org/10.1186/1471-2164-13-199
_version_ 1782243387790852096
author Joshi, Himanshu
Nord, Silje H
Frigessi, Arnoldo
Børresen-Dale, Anne-Lise
Kristensen, Vessela N
author_facet Joshi, Himanshu
Nord, Silje H
Frigessi, Arnoldo
Børresen-Dale, Anne-Lise
Kristensen, Vessela N
author_sort Joshi, Himanshu
collection PubMed
description BACKGROUND: The human genome contains a large amount of cis-regulatory DNA elements responsible for directing both spatial and temporal gene-expression patterns. Previous studies have shown that based on their mRNA expression breast tumors could be divided into five subgroups (Luminal A, Luminal B, Basal, ErbB2(+) and Normal-like), each with a distinct molecular portrait. Whole genome gene expression analysis of independent sets of breast tumors reveals repeatedly the robustness of this classification. Furthermore, breast tumors carrying a TP53 mutation show a distinct gene expression profile, which is in strong association to the distinct molecular portraits. The mRNA expression of 552 genes, which varied considerably among the different tumors, but little between two samples of the same tumor, has been shown to be sufficient to separate these tumor subgroups. RESULTS: We analyzed in silico the transcriptional regulation of genes defining the subgroups at 3 different levels: 1. We studied the pathways in which the genes distinguishing the subgroups of breast cancer may be jointly involved including upstream regulators (1(st) and 2(nd) level of regulation) as well as downstream targets of these genes. 2. Then we analyzed the promoter areas of these genes (−500 bp tp +100 bp relative to the transcription start site) for canonical transcription binding sites using Genomatix. 3. We looked for the actual expression levels of the identified TF and how they correlate with the overrepresentation of their TF binding sites in the separate groups. We report that promoter composition of the genes that most strongly predict the patient subgroups is distinct. The class-predictive genes showed a clearly different degree of overrepresentation of transcription factor families in their promoter sequences. CONCLUSION: The study suggests that transcription factors responsible for the observed expression pattern in breast cancers may lead us to important biological pathways.
format Online
Article
Text
id pubmed-3441847
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34418472012-09-18 Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes Joshi, Himanshu Nord, Silje H Frigessi, Arnoldo Børresen-Dale, Anne-Lise Kristensen, Vessela N BMC Genomics Research Article BACKGROUND: The human genome contains a large amount of cis-regulatory DNA elements responsible for directing both spatial and temporal gene-expression patterns. Previous studies have shown that based on their mRNA expression breast tumors could be divided into five subgroups (Luminal A, Luminal B, Basal, ErbB2(+) and Normal-like), each with a distinct molecular portrait. Whole genome gene expression analysis of independent sets of breast tumors reveals repeatedly the robustness of this classification. Furthermore, breast tumors carrying a TP53 mutation show a distinct gene expression profile, which is in strong association to the distinct molecular portraits. The mRNA expression of 552 genes, which varied considerably among the different tumors, but little between two samples of the same tumor, has been shown to be sufficient to separate these tumor subgroups. RESULTS: We analyzed in silico the transcriptional regulation of genes defining the subgroups at 3 different levels: 1. We studied the pathways in which the genes distinguishing the subgroups of breast cancer may be jointly involved including upstream regulators (1(st) and 2(nd) level of regulation) as well as downstream targets of these genes. 2. Then we analyzed the promoter areas of these genes (−500 bp tp +100 bp relative to the transcription start site) for canonical transcription binding sites using Genomatix. 3. We looked for the actual expression levels of the identified TF and how they correlate with the overrepresentation of their TF binding sites in the separate groups. We report that promoter composition of the genes that most strongly predict the patient subgroups is distinct. The class-predictive genes showed a clearly different degree of overrepresentation of transcription factor families in their promoter sequences. CONCLUSION: The study suggests that transcription factors responsible for the observed expression pattern in breast cancers may lead us to important biological pathways. BioMed Central 2012-05-22 /pmc/articles/PMC3441847/ /pubmed/22616941 http://dx.doi.org/10.1186/1471-2164-13-199 Text en Copyright ©2012 Joshi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Joshi, Himanshu
Nord, Silje H
Frigessi, Arnoldo
Børresen-Dale, Anne-Lise
Kristensen, Vessela N
Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
title Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
title_full Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
title_fullStr Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
title_full_unstemmed Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
title_short Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
title_sort overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441847/
https://www.ncbi.nlm.nih.gov/pubmed/22616941
http://dx.doi.org/10.1186/1471-2164-13-199
work_keys_str_mv AT joshihimanshu overrepresentationoftranscriptionfactorfamiliesinthegenesetsunderlyingbreastcancersubtypes
AT nordsiljeh overrepresentationoftranscriptionfactorfamiliesinthegenesetsunderlyingbreastcancersubtypes
AT frigessiarnoldo overrepresentationoftranscriptionfactorfamiliesinthegenesetsunderlyingbreastcancersubtypes
AT børresendaleannelise overrepresentationoftranscriptionfactorfamiliesinthegenesetsunderlyingbreastcancersubtypes
AT kristensenvesselan overrepresentationoftranscriptionfactorfamiliesinthegenesetsunderlyingbreastcancersubtypes